Patents by Inventor Elizabeth Pomfret

Elizabeth Pomfret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS
    Publication number: 20220127368
    Abstract: IL2-CCR4 bispecific immunotoxin, CCR4-IL2 bispecific immunotoxin, and methods of use thereof for treatment of refractory and recurrent human CD25+ and/or CCR4+ cutaneous T cell lymphoma, and other human CD25+ or CCR4+ tumors. The bispecific immunotoxin can be also used for broad cancer treatment via depleting CD25+ or CCR4+ Tregs.
    Type: Application
    Filed: February 19, 2020
    Publication date: April 28, 2022
    Inventors: Zhirui Wang, Christene Huang, David Mathes, Elizabeth Pomfret